Coverage for obesity drugs, including GLP1 medications, rose to 44% of large employers (500+ employees) in 2024, and 64% of the largest employers (20,000+ employees) now offer this coverage, according to data from Mercer
Some of them have had success with GLP-1 receptor agonists like Ozempic, but many of them still turn to us for their usual diabetic supplies
If a plan covers a branded product, your share may differ substantially
First, the approval came a mere 50 days from filing thanks to the FDA's new Commissioner's National Priority Voucher pilot, reportedly the fastest NME clearance since 2002
(Although how much of a reduction varies
Efficacy of supplementation with methylcobalamin and cyancobalamin in maintaining the level of serum holotranscobalamin in a group of plantbased diet (vegan) adults. Experimental and Therapeutic Medicine 22(3) (2021): 17